{"id":1650,"date":"2010-10-21T14:54:53","date_gmt":"2010-10-21T18:54:53","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=1650"},"modified":"2010-10-21T14:54:53","modified_gmt":"2010-10-21T18:54:53","slug":"implanted-device-treats-balance-disorder","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=1650","title":{"rendered":"Implanted Device Treats Balance Disorder"},"content":{"rendered":"<figure id=\"attachment_1654\" aria-describedby=\"caption-attachment-1654\" style=\"width: 200px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/VestibularImplant_CochlearLtd1.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-1654\" title=\"VestibularImplant_CochlearLtd\" src=\"http:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/VestibularImplant_CochlearLtd1.jpg\" alt=\"Vertigo treatment implant (Cochlear Ltd.)\" width=\"200\" height=\"250\" srcset=\"https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/VestibularImplant_CochlearLtd1.jpg 200w, https:\/\/technewslit.com\/sciencebusiness\/wp-content\/uploads\/2010\/10\/VestibularImplant_CochlearLtd1-120x150.jpg 120w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/a><figcaption id=\"caption-attachment-1654\" class=\"wp-caption-text\">(Cochlear Ltd.)<\/figcaption><\/figure>\n<p>On 21 October, a <a href=\"http:\/\/uwmedicine.washington.edu\/Pages\/default.aspx\">University of Washington Medical Center<\/a> (UW Medicine) patient will receive the world&#8217;s first device designed to quell vertigo associated with M\u00e9ni\u00e8re&#8217;s disease. The UW Medicine team that developed the implantable device plans a 10-person surgical trial of M\u00e9ni\u00e8re&#8217;s patients, which they hope will lead to its eventual use with other common balance disorders.<\/p>\n<p>M\u00e9ni\u00e8re\u2019s disease is a disorder of the inner ear &#8212; usually affecting one ear &#8212; that causes severe dizziness (vertigo), ringing in the ears (tinnitus), hearing loss, and a feeling of fullness or congestion in the ear. Its episodic attacks are thought to stem from the rupture of an inner-ear membrane. Endolymphatic fluid leaks out of the vestibular system, causing havoc to the brain&#8217;s perception of balance.<\/p>\n<p>The disease is most likely to occur in adults between 40 and 60 years of age. The <a href=\"http:\/\/www.nidcd.nih.gov\/health\/balance\/meniere.html\">National Institute on Deafness and Other Communication Disorders<\/a> estimates that approximately 615,000 individuals in the United States are currently diagnosed with M\u00e9ni\u00e8re\u2019s disease and that 45,500 cases are newly diagnosed each year.<\/p>\n<p>With their device, its developers &#8212; Jay Rubinstein and James Phillips of UW&#8217;s Department of Otolaryngology-Head and Neck Surgery &#8212; aim to restore the patient&#8217;s balance during attacks while leaving natural hearing and residual balance function intact. The patient wears a processor behind the affected ear (pictured left) and activates it as an attack starts. The processor wirelessly signals the device, which is implanted almost directly underneath in a small well created in the temporal bone. The device in turn transmits electrical impulses through three electrodes inserted into the canals of the inner ear&#8217;s bony labyrinth.<\/p>\n<p>Promising early test results on primates led the U.S. Food and Drug Administration, in June, to approve the device and the proposed surgical implantation procedure. <a href=\"http:\/\/www.cochlear.com\/\">Cochlear Ltd.<\/a>, a Australian medical equipment company and maker of devices for hearing-impaired people will manufacture the device.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 21 October, a University of Washington Medical Center (UW Medicine) patient will receive the world&#8217;s first device designed to quell vertigo associated with M\u00e9ni\u00e8re&#8217;s disease. The UW Medicine team that developed the implantable device plans a 10-person surgical trial of M\u00e9ni\u00e8re&#8217;s patients, which they hope will lead to its eventual use with other common [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,15],"tags":[31,28,77,26],"class_list":["post-1650","post","type-post","status-publish","format-standard","hentry","category-ventures","category-products","tag-biomedical","tag-clinical-trials","tag-medical-device","tag-university"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/1650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1650"}],"version-history":[{"count":4,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/1650\/revisions"}],"predecessor-version":[{"id":1656,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/1650\/revisions\/1656"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}